+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Region: Trend Forecast and Growth Opportunity

  • PDF Icon

    Report

  • 196 Pages
  • June 2022
  • Region: Global
  • GMD Research
  • ID: 5624809
Global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.



Highlighted with 80 tables and 89 figures, this 196-page report “Global Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Pre-filled Syringes
  • Multidose Eyedroppers
  • Squeeze Dispensers
  • Mist Sprayers
  • Contact Lenses
  • Ocular Inserts
  • Intraocular Implants
  • Punctal Plugs
  • Other Products

Based on Dosage Form, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Solutions
  • Gels
  • Ointments
  • Suspensions
  • Emulsions
  • Liposomes & Nanoparticles

By Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Glaucoma
  • Diabetic Retinopathy
  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Diabetic Macular Edema
  • Refractive Issues
  • Other Diseases

By Setting, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Hospitals
  • Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers (ASCs)
  • Other Settings

Geographically, the following regions together with the listed national/local markets are fully investigated:

  • North America (U.S., Canada, and Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (Israel, UAE,Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Dosage Form and Setting over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players

  • Aero Pump GmbH
  • Allergan plc.
  • AptarGroup, Inc.
  • Becton, Dickinson and Company
  • Biocorp
  • Clearside Biomedical, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Gaplast GmbH
  • Gerresheimer AG
  • Jotteq Inc.
  • Kedalion Therapeutics, Inc.
  • Mati Therapeutics, Inc.
  • Nemera
  • Nipro Corporation
  • Ocular Therapeutix, Inc.
  • Ocumedic, Inc.
  • Owen Mumford
  • Re-Vana Therapeutics
  • Silgan Holdings Inc.
  • Terumo Corporation
  • Valeant Pharmaceuticals International Inc. (Bausch Health Company)
  • West Pharmaceutical Services, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the Global Ophthalmic Drug Delivery System Market

What is the estimated value of the Global Ophthalmic Drug Delivery System Market?

The Global Ophthalmic Drug Delivery System Market was estimated to be valued at $15394.5 Million in 2021.

What is the growth rate of the Global Ophthalmic Drug Delivery System Market?

The growth rate of the Global Ophthalmic Drug Delivery System Market is 6.9%, with an estimated value of $30013.7 Million by 2031.

What is the forecasted size of the Global Ophthalmic Drug Delivery System Market?

The Global Ophthalmic Drug Delivery System Market is estimated to be worth $30013.7 Million by 2031.

Who are the key companies in the Global Ophthalmic Drug Delivery System Market?

Key companies in the Global Ophthalmic Drug Delivery System Market include Aero Pump GmbH, Allergan plc., AptarGroup, Inc., Becton, Dickinson and Company, Biocorp, Clearside Biomedical, Inc., EyePoint Pharmaceuticals, Inc., Gaplast GmbH and Jotteq Inc..

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 Segmentation of Global Market by Product
3.1 Market Overview by Product
3.2 Pre-filled Syringes
3.3 Multidose Eyedroppers
3.4 Squeeze Dispensers
3.5 Mist Sprayers
3.6 Contact Lenses
3.7 Ocular Inserts
3.8 Intraocular Implants
3.9 Punctal Plugs
3.10 Other Products
4 Segmentation of Global Market by Dosage Form
4.1 Market Overview by Dosage Form
4.2 Solutions
4.3 Gels
4.4 Ointments
4.5 Suspensions
4.6 Emulsions
4.7 Liposomes & Nanoparticles
5 Segmentation of Global Market by Disease
5.1 Market Overview by Disease
5.2 Glaucoma
5.3 Diabetic Retinopathy
5.4 Cataract
5.5 Dry Eye Syndrome
5.6 Macular Degeneration
5.7 Diabetic Macular Edema
5.8 Refractive Issues
5.9 Other Diseases
6 Segmentation of Global Market by Setting
6.1 Market Overview by Setting
6.2 Hospitals
6.3 Clinics
6.4 Homecare Settings
6.5 Ambulatory Surgical Centers (ASCs)
6.6 Other Settings
7 Segmentation of Global Market by Region
7.1 Geographic Market Overview 2021-2031
7.2 North America Market 2021-2031 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2021-2031 by Country
7.3.1 Overview of European Market
7.3.2 Germany
7.3.3 U.K.
7.3.4 France
7.3.5 Spain
7.3.6 Italy
7.3.7 Netherlands
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2021-2031 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 Japan
7.4.3 China
7.4.4 Australia
7.4.5 India
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2021-2031 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America Market
7.6 MEA Market 2021-2031 by Country
7.6.1 Israel
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Other National Markets
8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
  • Aero Pump GmbH
  • Allergan plc.
  • AptarGroup, Inc.
  • Becton, Dickinson and Company
  • Biocorp
  • Clearside Biomedical, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Gaplast GmbH
  • Gerresheimer AG
  • Jotteq Inc.
  • Kedalion Therapeutics, Inc.
  • Mati Therapeutics, Inc.
  • Nemera
  • Nipro Corporation
  • Ocular Therapeutix, Inc.
  • Ocumedic, Inc.
  • Owen Mumford
  • Re-Vana Therapeutics
  • Silgan Holdings Inc.
  • Terumo Corporation
  • Valeant Pharmaceuticals International Inc. (Bausch Health Company)
  • West Pharmaceutical Services, Inc.

List of Tables
Table 1. Snapshot of Global Ophthalmic Drug Delivery System Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Main Product Trends and Market Opportunities in Global Ophthalmic Drug Delivery System Market
Table 4. Global Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 5. Global Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 6. Global Ophthalmic Drug Delivery System Market by Disease, 2021-2031, $ mn
Table 7. Global Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 8. Global Ophthalmic Drug Delivery System Market by Region, 2021-2031, $ mn
Table 9. Leading National Ophthalmic Drug Delivery System Market, 2021 and 2031, $ mn
Table 10. North America Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn
Table 11. U.S. Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 12. U.S. Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 13. U.S. Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 14. Canada Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 15. Canada Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 16. Canada Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 17. Mexico Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 18. Mexico Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 19. Mexico Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 20. Europe Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn
Table 21. Germany Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 22. Germany Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 23. Germany Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 24. U.K. Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 25. U.K. Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 26. U.K. Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 27. France Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 28. France Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 29. France Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 30. Spain Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 31. Spain Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 32. Spain Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 33. Italy Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 34. Italy Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 35. Italy Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 36. Netherlands Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 37. Netherlands Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 38. Netherlands Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 39. Ophthalmic Drug Delivery System Market in Rest of Europe by Country, 2021-2031, $ mn
Table 40. APAC Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn
Table 41. Japan Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 42. Japan Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 43. Japan Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 44. China Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 45. China Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 46. China Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 47. Australia Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 48. Australia Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 49. Australia Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 50. India Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 51. India Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 52. India Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 53. South Korea Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 54. South Korea Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 55. South Korea Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 56. Ophthalmic Drug Delivery System Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 57. South America Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn
Table 58. Argentina Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 59. Argentina Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 60. Argentina Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 61. Brazil Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 62. Brazil Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 63. Brazil Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 64. Chile Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 65. Chile Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 66. Chile Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 67. MEA Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn
Table 68. Israel Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 69. Israel Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 70. Israel Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 71. Saudi Arabia Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 72. Saudi Arabia Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 73. Saudi Arabia Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 74. South Africa Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn
Table 75. South Africa Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn
Table 76. South Africa Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn
Table 77. Breakdown of World Market by Key Vendor, 2021, %
Table 78. Aero Pump GmbH: Company Snapshot
Table 79. Aero Pump GmbH: Business Segmentation
Table 80. Aero Pump GmbH: Product Portfolio
List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Industry Value Chain Analysis
Figure 5. Global Ophthalmic Drug Delivery System Market, 2021-2031, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Ophthalmic Drug Delivery System Market
Figure 8. Number of Population Affected by Vision Impairment, All Ages by Sex, 1990-2050F
Figure 9. Primary Restraints and Impact Factors of Global Ophthalmic Drug Delivery System Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of Global Ophthalmic Drug Delivery System Market
Figure 12. Breakdown of Global Ophthalmic Drug Delivery System Market by Product, 2021-2031, % of Revenue
Figure 13. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)
Figure 14. Global Ophthalmic Drug Delivery System Market by Product: Pre-filled Syringes, 2021-2031, $ mn
Figure 15. Global Ophthalmic Drug Delivery System Market by Product: Multidose Eyedroppers, 2021-2031, $ mn
Figure 16. Global Ophthalmic Drug Delivery System Market by Product: Squeeze Dispensers, 2021-2031, $ mn
Figure 17. Global Ophthalmic Drug Delivery System Market by Product: Mist Sprayers, 2021-2031, $ mn
Figure 18. Global Ophthalmic Drug Delivery System Market by Product: Contact Lenses, 2021-2031, $ mn
Figure 19. Global Ophthalmic Drug Delivery System Market by Product: Ocular Inserts, 2021-2031, $ mn
Figure 20. Global Ophthalmic Drug Delivery System Market by Product: Intraocular Implants, 2021-2031, $ mn
Figure 21. Global Ophthalmic Drug Delivery System Market by Product: Punctal Plugs, 2021-2031, $ mn
Figure 22. Global Ophthalmic Drug Delivery System Market by Product: Other Products, 2021-2031, $ mn
Figure 23. Breakdown of Global Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, % of Sales Revenue
Figure 24. Global Addressable Market Cap in 2022-2031 by Dosage Form, Value ($ mn) and Share (%)
Figure 25. Global Ophthalmic Drug Delivery System Market by Dosage Form: Solutions, 2021-2031, $ mn
Figure 26. Global Ophthalmic Drug Delivery System Market by Dosage Form: Gels, 2021-2031, $ mn
Figure 27. Global Ophthalmic Drug Delivery System Market by Dosage Form: Ointments, 2021-2031, $ mn
Figure 28. Global Ophthalmic Drug Delivery System Market by Dosage Form: Suspensions, 2021-2031, $ mn
Figure 29. Global Ophthalmic Drug Delivery System Market by Dosage Form: Emulsions, 2021-2031, $ mn
Figure 30. Global Ophthalmic Drug Delivery System Market by Dosage Form: Liposomes & Nanoparticles, 2021-2031, $ mn
Figure 31. Breakdown of Global Ophthalmic Drug Delivery System Market by Disease, 2021-2031, % of Sales Revenue
Figure 32. Global Addressable Market Cap in 2022-2031 by Disease, Value ($ mn) and Share (%)
Figure 33. Global Ophthalmic Drug Delivery System Market by Disease: Glaucoma, 2021-2031, $ mn
Figure 34. Global Ophthalmic Drug Delivery System Market by Disease: Diabetic Retinopathy, 2021-2031, $ mn
Figure 35. Global Ophthalmic Drug Delivery System Market by Disease: Cataract, 2021-2031, $ mn
Figure 36. Global Ophthalmic Drug Delivery System Market by Disease: Dry Eye Syndrome, 2021-2031, $ mn
Figure 37. Global Ophthalmic Drug Delivery System Market by Disease: Macular Degeneration, 2021-2031, $ mn
Figure 38. Global Ophthalmic Drug Delivery System Market by Disease: Diabetic Macular Edema, 2021-2031, $ mn
Figure 39. Global Ophthalmic Drug Delivery System Market by Disease: Refractive Issues, 2021-2031, $ mn
Figure 40. Global Ophthalmic Drug Delivery System Market by Disease: Other Diseases, 2021-2031, $ mn
Figure 41. Breakdown of Global Ophthalmic Drug Delivery System Market by Setting, 2021-2031, % of Revenue
Figure 42. Global Addressable Market Cap in 2022-2031 by Setting, Value ($ mn) and Share (%)
Figure 43. Global Ophthalmic Drug Delivery System Market by Setting: Hospitals, 2021-2031, $ mn
Figure 44. Global Ophthalmic Drug Delivery System Market by Setting: Clinics, 2021-2031, $ mn
Figure 45. Global Ophthalmic Drug Delivery System Market by Setting: Homecare Settings, 2021-2031, $ mn
Figure 46. Global Ophthalmic Drug Delivery System Market by Setting: Ambulatory Surgical Centers (ASCs), 2021-2031, $ mn
Figure 47. Global Ophthalmic Drug Delivery System Market by Setting: Other Settings, 2021-2031, $ mn
Figure 48. Global Market Snapshot by Region
Figure 49. Geographic Spread of Worldwide Ophthalmic Drug Delivery System Market, 2021-2031, % of Sales Revenue
Figure 50. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 51. North American Ophthalmic Drug Delivery System Market, 2021-2031, $ mn
Figure 52. Breakdown of North America Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue
Figure 53. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 54. U.S. Ophthalmic Drug Delivery System Market, 2021-2031, $ mn
Figure 55. Canada Ophthalmic Drug Delivery System Market, 2021-2031, $ mn
Figure 56. Ophthalmic Drug Delivery System Market in Mexico, 2021-2031, $ mn
Figure 57. European Ophthalmic Drug Delivery System Market, 2021-2031, $ mn
Figure 58. Breakdown of European Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue
Figure 59. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 60. Ophthalmic Drug Delivery System Market in Germany, 2021-2031, $ mn
Figure 61. Ophthalmic Drug Delivery System Market in U.K., 2021-2031, $ mn
Figure 62. Ophthalmic Drug Delivery System Market in France, 2021-2031, $ mn
Figure 63. Ophthalmic Drug Delivery System Market in Spain, 2021-2031, $ mn
Figure 64. Ophthalmic Drug Delivery System Market in Italy, 2021-2031, $ mn
Figure 65. Ophthalmic Drug Delivery System Market in Netherlands, 2021-2031, $ mn
Figure 66. Ophthalmic Drug Delivery System Market in Rest of Europe, 2021-2031, $ mn
Figure 67. Asia-Pacific Ophthalmic Drug Delivery System Market, 2021-2031, $ mn
Figure 68. Breakdown of APAC Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue
Figure 69. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 70. Ophthalmic Drug Delivery System Market in Japan, 2021-2031, $ mn
Figure 71. Ophthalmic Drug Delivery System Market in China, 2021-2031, $ mn
Figure 72. Ophthalmic Drug Delivery System Market in Australia, 2021-2031, $ mn
Figure 73. Ophthalmic Drug Delivery System Market in India, 2021-2031, $ mn
Figure 74. Ophthalmic Drug Delivery System Market in South Korea, 2021-2031, $ mn
Figure 75. Ophthalmic Drug Delivery System Market in Rest of APAC, 2021-2031, $ mn
Figure 76. South America Ophthalmic Drug Delivery System Market, 2021-2031, $ mn
Figure 77. Breakdown of South America Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue
Figure 78. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 79. Ophthalmic Drug Delivery System Market in Argentina, 2021-2031, $ mn
Figure 80. Ophthalmic Drug Delivery System Market in Brazil, 2021-2031, $ mn
Figure 81. Ophthalmic Drug Delivery System Market in Chile, 2021-2031, $ mn
Figure 82. Ophthalmic Drug Delivery System Market in Rest of South America, 2021-2031, $ mn
Figure 83. Ophthalmic Drug Delivery System Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 84. Breakdown of MEA Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue
Figure 85. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 86. Ophthalmic Drug Delivery System Market in Israel, 2021-2031, $ mn
Figure 87. Ophthalmic Drug Delivery System Market in Saudi Arabia, 2021-2031, $ mn
Figure 88. Ophthalmic Drug Delivery System Market in South Africa, 2021-2031, $ mn
Figure 89. Growth Stage of Global Ophthalmic Drug Delivery System Industry over the Forecast Period

Companies Mentioned

  • Aero Pump GmbH
  • Allergan plc.
  • AptarGroup, Inc.
  • Becton, Dickinson and Company
  • Biocorp
  • Clearside Biomedical, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Gaplast GmbH
  • Gerresheimer AG
  • Jotteq Inc.
  • Kedalion Therapeutics, Inc.
  • Mati Therapeutics, Inc.
  • Nemera
  • Nipro Corporation
  • Ocular Therapeutix, Inc.
  • Ocumedic, Inc.
  • Owen Mumford
  • Re-Vana Therapeutics
  • Silgan Holdings Inc.
  • Terumo Corporation
  • Valeant Pharmaceuticals International Inc. (Bausch Health Company)
  • West Pharmaceutical Services, Inc.

Methodology

Loading
LOADING...